Effects of Motivational Interviewing on Risky Injecting Practices Among Injecting Drug Users (IDUs)
NCT ID: NCT00794391
Last Updated: 2014-04-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
219 participants
INTERVENTIONAL
2008-11-30
2011-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Chronic Hepatitis Intervention Project for Drug Users
NCT00596843
Motivational Interviewing to Increase Uptake of Drug Checking and Safe Drug Use Behaviors to Reduce Overdose
NCT06855836
Motivational Interviewing Integrated With Social Network Counseling for Teens
NCT01922947
Does Delaying Adolescent Substance Use Lead to Improved Cognitive Function and Reduce Risk for Addiction?
NCT01655615
Computerized Brief Intervention vs. Delayed Computerized Brief Intervention
NCT01936623
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Motivational interviewing
Motivational interviewing is a client-centered, directive method for enhancing intrinsic motivation to change by exploring and resolving ambivalence (Miller \& Rollnick. 1993). This 45 minutes individual motivational intervention focuses on risky injection practices.
Motivational interviewing
Motivational interviewing is a client-centered, directive method for enhancing intrinsic motivation to change by exploring and resolving ambivalence (Miller \& Rollnick. 1993). This 45 minutes individual motivational intervention focuses on risky injection practices.
Educational intervention
The educational intervention is a 45 minutes individual intervention based on a document written by the Québec ministry of health (Québec, Canada). The aim is to inform participants about safe injection practices and to show them how to use sterile injection equipment.
Educational intervention
The educational intervention is a 45 minutes individual intervention based on a document written by the Québec ministry of health (Québec, Canada). The aim is to inform participants about safe injection practices and to show them how to use sterile injection equipment.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Motivational interviewing
Motivational interviewing is a client-centered, directive method for enhancing intrinsic motivation to change by exploring and resolving ambivalence (Miller \& Rollnick. 1993). This 45 minutes individual motivational intervention focuses on risky injection practices.
Educational intervention
The educational intervention is a 45 minutes individual intervention based on a document written by the Québec ministry of health (Québec, Canada). The aim is to inform participants about safe injection practices and to show them how to use sterile injection equipment.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* In the last month, at least one injection with a syringe or another piece of injection equipment that has been used by someone else
* 16 years old or more
* French speaking
* Being able to give informed consent
16 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fonds de la Recherche en Santé du Québec
OTHER_GOV
Université de Sherbrooke
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Karine Bertrand
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Karine Bertrand, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Université de Sherbrooke
Élise Roy, MD, MSc
Role: STUDY_CHAIR
Université de Sherbrooke
Carole Morissette, MD, FRCPC
Role: STUDY_CHAIR
Université de Montréal & Direction de santé publique de Montréal
Jean-François Boivin, MD, FRCPC
Role: STUDY_CHAIR
McGill University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Université de Sherbrooke, service de toxicomanie (Campus Longueuil)
Montreal, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
13940 (FRSQ ID)
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.